Precision medicine platform for oncology that integrates clinical and genomic data to improve cancer treatment outcomes.
Syapse is a healthcare technology company that develops precision medicine platforms for oncology care. The company operates in the digital health and precision medicine sector, providing software solutions that help healthcare providers and life sciences companies leverage real-world data to improve cancer treatment outcomes. Syapse's platform integrates clinical, genomic, and operational data to support personalized treatment decisions.
The company works with leading cancer centers and pharmaceutical companies to accelerate precision medicine adoption and clinical research. Syapse has raised venture funding to develop its data analytics capabilities and expand its presence in the oncology market, positioning itself at the intersection of healthcare IT and precision medicine during a period of rapid advancement in personalized cancer care.
Syapse has received investment from 2 venture capital firms.
Precision medicine platform for oncology that integrates clinical and genomic data to improve cancer treatment outcomes.
Syapse has received investment from 7wire Ventures, F-Prime Capital (fka Fidelity Biosciences). These venture capital firms and investors provide both capital and strategic support.
Syapse operates in the Digital Health sector. Precision medicine platform for oncology that integrates clinical and genomic data to improve cancer treatment outcomes.
